Annual Total Liabilities
$12.62 M
-$3.62 M-22.29%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual total liabilities is $12.62 million, with the most recent change of -$3.62 million (-22.29%) on December 31, 2023.
- During the last 3 years, APVO annual total liabilities has fallen by -$24.33 million (-65.85%).
- APVO annual total liabilities is now -77.21% below its all-time high of $55.38 million, reached on December 31, 2021.
Performance
APVO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$10.73 M
+$268.00 K+2.56%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly total liabilities is $10.73 million, with the most recent change of +$268.00 thousand (+2.56%) on September 30, 2024.
- Over the past year, APVO quarterly total liabilities has dropped by -$1.90 million (-15.01%).
- APVO quarterly total liabilities is now -81.59% below its all-time high of $58.25 million, reached on March 31, 2021.
Performance
APVO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
APVO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.3% | -15.0% |
| 3 y3 years | -65.8% | -15.0% |
| 5 y5 years | -66.0% | -74.2% |
APVO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.2% | at low | -80.6% | +2.6% |
| 5 y | 5-year | -77.2% | at low | -81.6% | +8.8% |
| alltime | all time | -77.2% | at low | -81.6% | +8.8% |
Aptevo Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.73 M(+2.6%) |
| Jun 2024 | - | $10.46 M(-9.3%) |
| Mar 2024 | - | $11.53 M(-8.7%) |
| Dec 2023 | $12.62 M(-22.3%) | $12.62 M(+1.7%) |
| Sep 2023 | - | $12.41 M(-2.0%) |
| Jun 2023 | - | $12.66 M(+8.1%) |
| Mar 2023 | - | $11.71 M(-27.9%) |
| Dec 2022 | $16.24 M(-70.7%) | $16.24 M(+1.9%) |
| Sep 2022 | - | $15.93 M(+1.1%) |
| Jun 2022 | - | $15.75 M(-69.2%) |
| Mar 2022 | - | $51.07 M(-7.8%) |
| Dec 2021 | $55.38 M(+49.9%) | $55.38 M(-2.3%) |
| Sep 2021 | - | $56.71 M(-1.5%) |
| Jun 2021 | - | $57.59 M(-1.1%) |
| Mar 2021 | - | $58.25 M(+57.6%) |
| Dec 2020 | $36.95 M | $36.95 M(+4.9%) |
| Sep 2020 | - | $35.22 M(+257.2%) |
| Jun 2020 | - | $9.86 M(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $10.09 M(-75.7%) |
| Dec 2019 | $41.57 M(+12.1%) | $41.57 M(+1.8%) |
| Sep 2019 | - | $40.81 M(+2.2%) |
| Jun 2019 | - | $39.93 M(-4.3%) |
| Mar 2019 | - | $41.71 M(+12.5%) |
| Dec 2018 | $37.09 M(+6.1%) | $37.09 M(+6.2%) |
| Sep 2018 | - | $34.93 M(+2.8%) |
| Jun 2018 | - | $33.97 M(+6.7%) |
| Mar 2018 | - | $31.85 M(-8.9%) |
| Dec 2017 | $34.97 M(-15.3%) | $34.97 M(-14.1%) |
| Sep 2017 | - | $40.71 M(+14.8%) |
| Jun 2017 | - | $35.47 M(-2.3%) |
| Mar 2017 | - | $36.31 M(-12.1%) |
| Dec 2016 | $41.29 M(+5.5%) | $41.29 M(+12.0%) |
| Sep 2016 | - | $36.87 M(+75.9%) |
| Jun 2016 | - | $20.96 M(-7.8%) |
| Mar 2016 | - | $22.74 M(-41.9%) |
| Dec 2015 | $39.15 M(+54.4%) | $39.15 M |
| Dec 2014 | $25.36 M | - |
FAQ
- What is Aptevo Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual total liabilities year-on-year change?
- What is Aptevo Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly total liabilities year-on-year change?
What is Aptevo Therapeutics annual total liabilities?
The current annual total liabilities of APVO is $12.62 M
What is the all time high annual total liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual total liabilities is $55.38 M
What is Aptevo Therapeutics annual total liabilities year-on-year change?
Over the past year, APVO annual total liabilities has changed by -$3.62 M (-22.29%)
What is Aptevo Therapeutics quarterly total liabilities?
The current quarterly total liabilities of APVO is $10.73 M
What is the all time high quarterly total liabilities for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly total liabilities is $58.25 M
What is Aptevo Therapeutics quarterly total liabilities year-on-year change?
Over the past year, APVO quarterly total liabilities has changed by -$1.90 M (-15.01%)